Related Experiment Video
Updated: Sep 1, 2025

09:52
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
9.5K
The Use of Nanoparticles in Otoprotection
Maurizio Barbara1, Valerio Margani1, Edoardo Covelli1
1Department of Neuroscience, Mental Health and Sensory Organs, Faculty of Medicine and Psychology, Sapienza University, Rome, Italy.
Frontiers in Neurology
|August 15, 2022
Summary
Nanoparticles effectively deliver otoprotective drugs to the inner ear, preserving hearing from damage caused by chemotherapy and noise. These biocompatible nanoparticles improve drug delivery and efficacy, showing promise for clinical trials.
Area of Science:
- Ototoxicology
- Nanomedicine
- Drug Delivery
Background:
- Inner ear damage from ototoxic stimuli (drugs, noise) causes progressive hearing loss.
- Systemic drugs struggle to reach the inner ear due to poor blood supply and barriers.
- Nanoparticles offer a novel approach to overcome these delivery challenges.
Purpose of the Study:
- To review the use of nanoparticles (NPs) for otoprotection against inner ear damage.
- To evaluate the biocompatibility and efficacy of drug-loaded NPs.
Main Methods:
- Review of in vitro and in vivo studies on NP biocompatibility and otoprotection.
- Analysis of nano-formulation techniques (encapsulation, surface functionalization) to enhance drug delivery.
- Assessment of drug-NP efficacy in preventing hair cell damage and hearing loss.
Main Results:
- NPs demonstrated good biocompatibility, with no significant decrease in cell viability or ototoxicity.
- Nano-formulations improved drug transmission through the round window membrane (RWM).
- Drug-loaded NPs effectively preserved hair cells and hearing function against ototoxic stimuli.
Conclusions:
- Nanoparticles are a promising strategy for otoprotection, enhancing drug delivery to the inner ear.
- Drug-loaded NPs, particularly with dexamethasone and antioxidants, show significant potential.
- Successful preclinical studies pave the way for human clinical trials in otoprotection.

